Berries Women Health Pharmacogenetics (PGx) Test
$499.00
Berries Health and Genetics offers pharmacogenomics (PGx) testing to personalize medication selection for treating hypoactive sexual desire disorder (HSDD), like with Addyi. This testing optimizes treatment outcomes by tailoring prescriptions to genetic traits, reducing side effects, and preventing adverse interactions, ensuring safer and more effective care.
Female Sexual Disorders
Are you considering medications to treat hypoactive (low) sexual desire disorder (HSDD)? Selecting the right medication, like Addyi for HSDD, can be challenging. However, Berries Health and Genetics PGx testing offers personalized insights into medication responses, improving treatment outcomes and reducing potential adverse events or drug-drug interaction. Personalized Medication Selection: Pharmacogenomics analyzes genetic factors influencing medication responses. For example, Addyi may suit specific genetic traits in women with HSDD.
Optimized Treatment Outcomes: Genetic insights enable healthcare providers to prescribe the most effective medication from the start, increasing success rates and improving overall treatment outcomes. Reduced Side Effects: By identifying predispositions to medication side effects, pharmacogenomics testing allows for safer medication choices, minimizing discomfort and improving treatment compliance.
